
Following a strong earnings report, the subsequent price drop in Grab (GRAB) is being viewed as a buying opportunity by some investors who believe in its long-term growth. A potential deal to have Medicare cover obesity drugs from Eli Lilly (LLY) and Novo Nordisk (NVO) for $149/month represents a significant bullish catalyst for both stocks. Palantir (PLTR) experienced a price drop despite a blowout quarter, which could be a consolidation period for long-term believers in the company's AI dominance. Bitcoin (BTC) is showing significant weakness, and investors should watch the critical $100,000 psychological support level as a break below could lead to further selling. Despite a major short-seller bet, NVIDIA (NVDA) remains a core AI holding with demand appearing strong enough to overcome the loss of the Chinese market.
Here are the investment insights from the podcast transcript.

By @amitinvesting
Breaking down stocks, business, tech. Thank you for following along the journey!